ExodusPoint Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Buy |
+45,413
| New | +$230K | ﹤0.01% | 1223 |
|
|
2024
Q2 | – | Sell |
-61,689
| Closed | -$615K | – | 1779 |
|
|
2024
Q1 | $615K | Buy |
+61,689
| New | +$615K | ﹤0.01% | 977 |
|
|
2023
Q2 | – | Sell |
-31,137
| Closed | -$208K | – | 2088 |
|
|
2023
Q1 | $208K | Buy |
+31,137
| New | +$208K | ﹤0.01% | 1473 |
|
|
2022
Q4 | – | Sell |
-45,832
| Closed | -$488K | – | 2000 |
|
|
2022
Q3 | $488K | Sell |
45,832
-146,241
| -76% | -$1.56M | 0.01% | 1347 |
|
|
2022
Q2 | $1.56M | Buy |
192,073
+158,360
| +470% | +$1.29M | 0.02% | 848 |
|
|
2022
Q1 | $241K | Buy |
+33,713
| New | +$241K | ﹤0.01% | 1782 |
|